Tumor necrosis factor (TNF) ␣ is an important physiological mediator of cell-to-cell communication. Recent observations suggest that TNF␣ is involved in the control of reproductive functions. The present study examined the role of TNF␣ in the secretion of factors involved in regulating smooth muscle contraction, such as prostaglandin E 2 (PGE 2 ), prostaglandin F 2␣ (PGF 2␣ ), endothelin-1 (ET-1), and angiotensin II (Ang II), as it was in the original by the cow oviduct at different stages of the estrous cycle using an in vitro microdialysis system. Expression of mRNA for TNF␣ and its receptors (TNF␣-R) was also evaluated. For microdialysis, the lumen of a portion (length, 10 cm) of the each oviductal segment was implanted with a dialysis capillary membrane, and TNF␣ (100 ng/ml) was infused for 4-8 h during a 16-h incubation period. The microdialysis system maintains cell-to-cell integrity and cell-to-cell communication, and it enables real-time observation of physiological changes in the luminal release of different substances. Concentrations of PG, ET-1, and Ang II in 4-h fractions were measured using second-antibody enzyme immunoassays. Infusion of TNF␣ stimulated oviductal secretion of PG, ET-1, and Ang II during the follicular and postovulatory stages, but not during the luteal stage. Expression of TNF␣, TNF␣-R type I, and TNF␣-R type II mRNA was detected in the bovine oviduct by reverse transcriptionpolymerase chain reaction. High expression of both TNF␣R types and ligands was detected during the follicular and postovulatory stages, whereas low expression was detected during the luteal stage. The results of the present study provide, to our knowledge, the first direct evidence that TNF␣ stimulates PG, ET-1, and Ang II secretion and that up-regulation of the TNF␣ system occurs in the cow oviduct during the periovulatory period. In conclusion, the TNF␣ system may optimize the release of contraction-related substances and modulate local contraction to regulate the oviductal transport of the gametes and embryo.
INTRODUCTION
Tumor necrosis factor (TNF) ␣ is a cytokine that mediates cell-to-cell communication. This cytokine was initially identified as an up-and down-regulator of immunologic, inflammatory, and reparative host responses to injury. The existence of the bioactive form of this proinflammatory cytokine, as well as of its binding sites in the various reproductive tissues, has been reported. It has been postulated that the bioactive form of TNF␣ interacts with other substances to control reproductive functions [1] [2] [3] [4] [5] . It was reported that specific receptors for TNF␣ (TNF␣-R) are present in the bovine endometrium and that TNF␣ may trigger the release of luteolytic prostaglandin F 2␣ (PGF 2␣ ) [3] . In addition, human [6] and rat [7] preimplantation-stage embryos have been shown to express TNF␣-R. Ligands for TNF␣ have been shown to be secreted by the supporting tissues of the oviduct and uterus and, in some cases, by the embryo itself [8] . Moreover, the TNF gene is expressed in mouse oviductal epithelial cells [5] , and human oviductal fluid contains TNF␣ [4] .
Local production of prostaglandin E 2 , (PGE 2 ), PGF 2␣ , endothelin-1 (ET-1), and angiotensin II (Ang II) as well as their involvement in the cyclic regulation of functions have been studied extensively in the cow oviduct. F-series PGs are involved in oviductal contraction, whereas E-series PGs relax smooth muscle [9] . Moreover, ET-1 is locally involved in muscular oviductal contraction [10] . Local PGs and ET-1 concentrations in the cow oviduct are highest during the periovulatory period of the estrous cycle [11] , and PG, ET-1 [12] , and Ang II [13] directly increase the contractile amplitude of the cow oviduct in vitro.
Stimulatory effects of TNF␣ on the biosynthesis and release of PG [14] [15] [16] [17] [18] [19] , ET-1 [20] [21] [22] , and Ang II [23, 24] have been reported in various tissues. However, the role of TNF␣ in regulating oviductal secretion of PG, ET-1, and Ang II, which are the main contraction-related substances in the oviduct, is not known. In the present study, we investigated the effect of TNF␣ on secretion of PGE 2 , PGF 2␣ , ET-1, and Ang II by the cow oviduct using an in vitro microdialysis system. In addition, mRNA expressions for TNF␣ and for TNF␣-R were evaluated in oviducts collected from the follicular, postovulatory, and luteal stages.
MATERIALS AND METHODS

Animals and Sample Collection
Whole reproductive tracts were collected from nonpregnant Holstein cows at a local slaughterhouse within 20 min of slaughter. The stage of the estrous cycle was defined as previously described [11, 25] based on the morphology of the corpus luteum, uterine fluid and cervical mucus characteristics, and luteal progesterone (P 4 ) levels. For microdialysis experiments, oviducts were separated from the uterotubal junction, and the surrounding connective tissues were trimmed. The oviducts were transported to the laboratory in Medium 199 (M199; 25 mmol/L of Hepes, 0.85 g/L of NaHCO 3 , 60 mg/L of penicillin, 100 mg/L of streptomycin, 56 mg/L of ascorbic acid, and 2 mg/L of amphotericin B; Sigma Chemical Co., St. Louis, MO), maintained at 38ЊC. The ampullary and isthmus regions of both oviducts were used.
For RNA extraction, oviducts from Holstein cows were collected at the slaughterhouse and transported on ice to the laboratory. Whole oviducts were filled with 1 ml of PBS, and the oviductal contents were squeezed into a 1.5-ml microcentrifuge tube. After centrifugation at 570 ϫ g for 3 min at 4ЊC, the supernatant was removed, and cell pellets of both oviducts of one cow were combined and stored at Ϫ70ЊC until examined. Cell types (Ͼ60% epithelial cells) and oviductal cell viability (Ͼ99%) were verified as described previously [26] .
In Vitro Microdialysis of Bovine Oviduct
The in vitro microdialysis of the oviduct has been described previously [12, 13] . The lumen of each oviductal segment (length, 10 cm) was implanted with a dialysis capillary membrane (length, 7 cm; diameter, 0.2 mm; cutoff, 1000 kDa; Fresenius SPS 600 Hollow Fiber; Fresenius AG, St. Wendel, Germany) of the microdialysis. The oviductal segment was incubated in M199 with 0.5% BSA (Sigma) in simple organ culture chambers (modified 50-ml Falcon tubes; Becton Dickinson & Co, Franklin Lakes, NJ). Four oviducts were maintained in each organ culture chamber, and the medium was continuously exchanged at a flow rate of 50 ml/h during the whole period of incubation. The chambers were maintained in a water bath at 38ЊC. Ringer solution was continuously perfused (1.3 ml/ h) from one end of the microdialysis using a peristaltic pump; the other end was connected to a fraction collector. After a 2-h preincubation, the perfusate was collected in 4-h fractions for 16 h. Control (Ringer solution only) or TNF␣ (100 ng/ml; DAINIPPON Pharmaceutical Co., Ltd., Osaka, Japan) in Ringer solution were infused at 4-8 h of incubation. The 4-h fractions of perfusate were stored at Ϫ20ЊC until extraction for PG and peptides.
Hormone Extraction
Prostaglandin and ET-1 extractions from microdialysis samples were performed as described earlier [27] . The Ang II extraction was done according to the procedure for ET-1. For PG extraction, the 5.2-ml microdialysis fractions were allowed to reach room temperature, adjusted to pH 3.5 with 1 N HCl, and then maintained at room temperature for 1 h. Next, five volumes of diethyl ether were added, and the mixture was shaken for 30 min at a frequency of 250 cycles/min (Shaker SA 31; Yamato Co., Tokyo, Japan). The samples were then allowed to stand for 15 min and placed in a Ϫ80ЊC freezer for 1 h. The upper diethyl ether fraction was decanted and evaporated. The residue was dissolved in 400 l of assay buffer for enzyme immunoassays (EIAs) for PG (40 mM PBS and 0.1% BSA; pH 7.2). After the diethyl ether extraction, the remaining Ringer solution was used for ET-1 and Ang II extraction. The BSA was added to the samples to a final concentration of 1 mg/ml, and the pH was adjusted to 2.5 with acetic acid. The samples were then applied to a Sep-Pak C18 Cartridge (Waters, Millford, MA), evaporated, and then dissolved in 100 l of assay buffer for the peptide EIA (42 mM Na 2 HPO 4 , 8 mM KH 2 PO 4 , 20 mM NaCl, 4.8 mM EDTA, and 0.05% BSA; pH 7.5). As a result of these extractions, PG and peptides (ET-1 and Ang II) were 13-and 52-fold more concentrated, respectively, than in the original samples. Recovery rates were estimated by adding three different concentrations each of PGE 2 (1, 0.5, and 0.1 ng/ml), PGF 2␣ (1, 0.5, and 0.1 ng/ml), ET-1 (10, 5, and 1 pg/ml), and Ang II (1, 10, and 100 pg/ml) to the Ringer solution before extraction. The recovery rates were 78% for PGE 2 , 75% for PGF 2␣ , 63% for ET-1, and 90% for Ang II.
Measurements of PG, ET-1, and Ang II
The EIAs for the PGE 2 , PGF 2␣ , ET-1, and Ang II assays were performed according to the methods of Wijayagunawardane et al. [11] , Miyamoto et al. [28] , Miyamoto et al. [29] , and Hayashi and Miyamoto [30] , respectively. Within-assay and between-assay coefficients of variation were 7.3% and 11.4%, respectively, for PGE 2 ; 8.2% and 11.8%, respectively, for PGF 2␣ ; 9.6% and 13.2%, respectively, for ET-1; and 2.67% and 7.99%, respectively, for Ang II. The median effective doses for the PGE 2 , PGF 2␣ , ET-1, and Ang II assays were 260, 355, 450, and 150 pg/ml, respectively, and the ranges of the standard curves for these assays were 0.03-14.2, 0.007-7.1, 0.01-20, and 0.024-5 ng/ml, respectively.
RNA Extraction
Total RNA was extracted from flushed oviductal cells following the protocol of Chomczynski and Sacchi [31] using TRIzol reagent (Gibco BRL, Gaithersburg, MD). The yield of extracted total oviductal RNA for each sample was determined by ultraviolet (UV) spectroscopy (optical density, 260 nm). The quantity and integrity of the oviductal RNAs were verified by checking the 28S and 18S ribosomal RNA bands after electrophoresis on a formaldehyde-containing 1% (w/v) agarose gel.
Reverse Transcription-Polymerase Chain Reaction
Genomic DNA contamination was removed from RNA samples by DNA digestion as described previously [32] . Briefly, DNase I treatment was carried out in a 20-l volume that contained 4 g of total oviductal RNA, 4 U of DNase I (Ambion, Austin, TX), 50 mM Tris-HCl (pH 8.3), 75 mM KCl, and 3 mM MgCl 2 . This reaction mixture was incubated at 37ЊC for 30 min and then heated at 75ЊC for 5 min to inactivate the DNase. Next, the samples were placed immediately on ice. To each sample was added 140 U of Superscript II reverse transcriptase (Gibco BRL), 2.5 M random hexamers (Amersham Biosciences, Piscataway, NJ), 0.60 mM dNTPs (Amersham), and 10 mM dithiothreitol for a final volume of 60 l. Reverse transcription (RT) was performed at 45ЊC for 30 min, followed by 90ЊC for 2 min. Commercially synthesized primers (Invitrogen Life Technologies, Carlsbad, CA) ( Table 1) were used to amplify specific bovine transcripts.
Each polymerase chain reaction (PCR) contained 5 l of cDNA, 0.2 mM dNTPs, 0.4 mol of each primer, 0.5 U of Taq DNA Polymerase (Qiagen, Valencia, CA), and a 1:10 dilution of the 10ϫ Qiagen PCR buffer (supplied with the polymerase) in a final volume of 25 l. The following individual amplification programs (94ЊC for 30 sec and 60ЊC for 1 min) were run in a thermocycler (Personal Cycler; Biometra, Göttingen, Germany) for each factor: 34 cycles for TNF␣, 27 cycles for TNF␣-R type I (TNF␣-RI), and 34 cycles for TNF␣-R type II (TNF␣-RII), respectively. All PCR programs started with an initial denaturation step at 94ЊC for 2 min and ended with a final elongation phase at 72ЊC for 2 min.
For each sample, 18S rRNA (324 base pairs) was amplified by RT-PCR to check the integrity of the RNA as well as the efficiency of the RT. The relative amount of the ribosomal 18S RNA was similar among the samples for phases of the estrous cycle. Therefore, the 18S rRNA PCR was used as the internal control for the experiments, and 18S primers and the appropriate competitors (both from Ambion) were used in a ratio of 2:3. Twenty-four amplification cycles were performed (94ЊC, 60ЊC, and 72ЊC for 30 sec each). Five microliters from each reaction were run on a 1.5% (w/v) agarose gel containing 1 g/ml of ethidium bromide. The resultant bands under UV light were documented with the Eagle Eye video system (Stratagene, La Jolla, CA) and analyzed with the Gel-Pro Analyzer software (Media Cybernetics, Silver Spring, MD). All RT-PCR reactions were performed twice for each RNA sample. To ensure that reactions did not reach a plateau in synthesis, preliminary experiments were done with an increasing number of cycles to determine the linear range of cycles for each primer set.
The PCR products were cut from the gel and eluted using a QIA quick gel extraction kit (Qiagen). The purified PCR products were sequenced using their respective forward primers (Penn State Life Sciences Facility, University Park, PA) to confirm specific amplification of PCR products. As negative controls, reactions containing no template (H 2 O) or non-reverse transcribed RNA were included to verify that the obtained PCR products were not derived from contaminations or genomic DNA. For all oviductal RNA samples, products were obtained for the corresponding cDNA, but not for genomic DNA under the above-described conditions.
Statistical Analysis
The absolute amounts of PGE 2 , PGF 2␣ , ET-1, and Ang II released into each microdialysis capillary membrane varied among individual oviducts (i.e., among individual cows). Thus, the mean concentration of these substances in the first 4 h of incubation (perfusion with Ringer solution only) was used to calculate the baseline for each hormone (defined as 100%), and all values were expressed as a percentage of the corresponding baseline. This transformation enables an evaluation of relative changes in the hormonal levels between different oviducts. The effect of the TNF␣ infusion on the release of PGE 2 , PGF 2␣ , ET-1, and Ang II was compared with control values during the same time period using ANOVA followed by the Duncan new multiple-range test. The data were subjected to the arcsine transformation before statistical analysis. Expressions of TNF␣, TNF␣-RI, and TNF␣-RII during different stages of the estrous cycle were analyzed using ANOVA. When ANOVA showed significant differences, the Tukey-Kramer test was used to test the significant differences. A probability level of P Ͻ 0.05 was considered to be significant.
RESULTS
During microdialysis, the basal release of PGE 2 , PGF 2␣ , ET-1, and Ang II from oviducts of the follicular and postovulatory stages were higher (P Ͻ 0.05) than the values obtained from oviducts of the luteal stage ( Table 2 ). This basal release of substances in the control group (Ringer solution only) was constant during the 16-h experimental period. Neither the basal release nor the extent of the stimulation by the infusion of different substances significantly differed between oviducts from the same animal or between the ampullar and isthmic parts of the same oviduct.
Effect of TNF␣ Infusion in Microdialyzed Cow Oviduct Collected During Different Stages of the Estrous Cycle
The 4-h infusion of TNF␣ in the postovulatory stage resulted in a 2-fold increase in release of PGE 2 (P Ͻ 0.05 to 0.01), which continued up to 16 h. During the follicular phase, this was only observed during the infusion (P Ͻ 0.01). The TNF␣ infusion caused an acute and continued, 5-to 10-fold increase in PGF 2␣ release (P Ͻ 0.05 to 0.01) both in follicular-and postovulatory-stage oviducts (Fig. 1) . The TNF␣ induced an approximately 2-fold increase in the release of ET-1 (P Ͻ 0.05) in postovulatory-stage oviducts up to 12 h; however, the stimulation in the follicular-stage oviducts was only observed during infusion (P Ͻ 0.001).
In postovulatory-stage oviducts, TNF␣ induced a 3-fold increase in secretion of Ang II (P Ͻ 0.001) between 8 and 12 h of incubation. In follicular-stage oviducts, TNF␣ stimulated Ang II secretion (P Ͻ 0.01), but only during infusion. During the luteal stage, TNF␣ did not stimulate any of the measured substances (Fig. 2) .
Expression of mRNA for TNF␣, TNF␣-RI, and TNF␣-RII
Specific transcripts for TNF␣, TNF␣-RI, and TNF␣-RII were detected in bovine oviductal cells. Each PCR product showed 100% homology to the known bovine genes after sequencing. The same expression pattern for TNF␣ and both TNF␣-RI and TNF␣-RII was found during the estrous cycle: higher expression during follicular and postovulatory stages, compared with lower expression during the luteal stage (Fig. 3) . This expression pattern was significant (P Ͻ 0.05) for both receptor types, as shown by ANOVA. Expression of TNF␣ was significantly higher during the postovulatory stage than during the luteal stage (P Ͻ 0.05).
DISCUSSION
The present study provides, to our knowledge, the first direct evidence that TNF␣ stimulates PG, ET-1, and Ang II secretion in the cow oviduct. Moreover, TNF␣ and its receptors are highly expressed in the cow oviduct during the periovulatory period, thus accounting for up-regulation of the TNF␣ system compared with the luteal stage. With the microdialysis system, the luminal epithelium of the oviduct collected during different stages of the estrous cycle was gently flushed. This system allows cell-to-cell integrity and cell-to-cell communication to be maintained, and it en- ables observations of real-time changes in the luminal release of different substances [12, 13] .
Studies of spontaneous oviductal contractions in the cow revealed low amplitude and frequency during the luteal phase [33] and a gradual increase in amplitude and frequency concomitant with a rapid decrease in P 4 levels [34] . Both amplitude and frequency reach their maximal value during estrus, and values quickly diminish over the next 3 days [33, 34] . During the active periovulatory period, elevated local distributions of PG and ET-1 were observed in the cow oviduct [11] , as was the stimulation of local oviductal PG and ET-1 [12, 13, 35, 36] secretion. In the present study, oviducts collected around the time of ovulation had TNF␣-stimulated release of all the investigated substances.
Infusion of TNF␣ into microdialyzed cow oviducts collected during the follicular and postovulatory stages clearly stimulated release of PG in the present study. The TNF␣ is known to stimulate both PGE 2 and PGF 2␣ secretion by the bovine endometrium through activation of phospholipase (PL) A 2 and arachidonic acid conversion [14, 15] . The TNF␣-induced PG release by cultured human amnion cells [16] , gingival fibroblasts [17] , and brain microvessel endothelial cells [18] through activation of cyclooxygenase (COX)-2 has also been recorded. Moreover, TNF␣-stimulated PGE 2 biosynthesis by amnion-derived AV3 cells was accompanied by increased prostaglandin H synthase 2 (PGHS) mRNA expression [19] . Therefore, the increased PG secretion by the cow oviduct following infusion of TNF␣ that we observed may be mediated through the activation of PLA 2 , COX-2, or PGHS.
In the present study, TNF␣ stimulated ET-1 release in the oviduct. In human mesangial cells [20] and bovine pulmonary arterial smooth muscle cells [37] , TNF␣-stimulated synthesis and release of ET-1 was the result of up-regulation of prepro-ET-1 mRNA. Moreover, TNF␣ stimulated ET-converting enzyme-1 mRNA expression in human normal bronchial epithelial cells, with a significant increase in ET-1 expression at both the mRNA and peptide levels [21] . In addition, TNF␣ induced higher levels of ET-1 in human ciliary nonpigmented epithelial cells, and this was accompanied by protein kinase C activation [22] . Elevated ET-1 levels in the cow oviduct induced by TNF␣ may facilitate oviductal contraction during the periovulatory period. Our recent study showed that the addition of ET-1 to organ culture medium rapidly increases the contractile amplitude of periovulatory bovine oviducts [12] . On the other hand, TNF␣ has been reported to increase ET-B receptor mRNA expression in human endothelial cells [38] and ET-B receptor-mediated contraction in rat superior mesenteric artery [39] . Thus, TNF␣ may further intensify the ET-1 action on the oviduct through up-regulation of ET-B receptors.
The results of the present study clearly demonstrate that TNF␣ stimulates the release of Ang II into the microdialysis system. In cultured fibroblasts, TNF␣ has been reported to up-regulate type 1 Ang II-receptor mRNA and protein fibroblasts [23, 24] . In pregnant rat [40] and sheep [41] , Ang II increased PG production, and Ang II stimulated release of ET-1 [42] and induction of prepro-ET-1 mRNA by the endothelial cells [43] . We recently observed that Ang II stimulates the secretion of PG and ET-1 in the microdialyzed cow oviduct [13] . Therefore, Ang II may be a local intermediator of TNF␣ that stimulates PG and ET-1 secretion during the periovulatory period, in addition to directly acting on oviductal smooth muscle.
We observed a clear, stage-specific mRNA expression for TNF␣ and for TNF␣-R during the estrous cycle. Progesterone is a potent inhibitor of TNF␣ mRNA expression and TNF␣ protein production in the endometrium of ruminants [1] and in activated mouse macrophages [44] . Thus, the low expression of mRNA for TNF␣ and for TNF␣-R observed in the present study during the luteal stage may result from the inhibitory action of P 4 . High levels of TNF␣ and TNF␣-R expression in the cow oviduct during the follicular and postovulatory stages are consistent with a previous report that the level of TNF␣ was highest in the mouse uterus during proestrus and/or estrus [45] , a time when the estradiol 17␤:P 4 ratio is increasing.
In the reproductive tract, a variety of immune cells are present, and their number and distribution vary in a tissuespecific manner with the stage of the estrous cycle [2] . Thus, a potential source for the TNF␣ in the oviduct may be immune cells present in the oviduct. Cyclic changes in the number of immune cells have been reported that may account for the stage differences in TNF␣ mRNA expression observed in the present study. However, because the embryo produces and secretes TNF␣ [46, 47] during oviductal passage, the ability of the embryo to act as a source of TNF␣ in the oviduct cannot be excluded. Human embryos at the 6-to 8-cell stage secrete TNF␣ [46] , and a dramatic enhancement in TNF␣ secretion occurs in bovine oocytes 48 h after fertilization [47] . The minute quantities of TNF␣ secreted by the embryo may act locally to enhance the production of PG, ET-1, and Ang II in the oviduct, which may result in an active oviductal contraction in the microenvironment around the embryo. This may ensure that the embryo migrates into the uterus at the optimal time.
In recent studies, we showed that LH in combination with a basal level of P 4 and a high concentration of E 2 has a maximal stimulatory effect on the oviductal secretion of PG and ET-1 during the periovulatory period [12, 35, 36] . The findings of the present study that TNF␣ stimulates maximal secretion of PGE 2 , PGF 2␣ , ET-1, and Ang II in the cow oviduct during the periovulatory period suggest that TNF␣ may act synergistically with LH, E 2 , and P 4 . In conclusion, the TNF␣ system in the oviduct may act to optimize the release of contraction-related substances and, thereby, modulate local contraction to regulate oviductal transport of the gametes and embryo.
